Transcription of ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
{{id}} {{{paragraph}}}
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Olumiant 2 mg film-coated tablets Each film-coated tablet contains 2 mg baricitinib. Olumiant 4 mg film-coated tablets Each film-coated tablet contains 4 mg baricitinib. For the full list of excipients, see section 3. PHARMACEUTICAL FORM Film-coated tablet (tablet) Olumiant 2 mg film-coated tablets Light pink, 9 x mm oblong tablets, debossed with Lilly on one side and 2 on the other.
anti-rheumatic drugs. Baricitinib may be used as monotherapy or in combination with methotrexate (see sections 4.4, 4.5 and 5.1 for available data on different combinations). ... biologic and conventional disease- modifying antirheumatic drugs (DMARDs). If a patient develops herpes zoster, treatment should be temporarily interrupted until the ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}